Brian Chhoy

Mar 1, 2024 | journals.healio.com | Brian Chhoy |Karen M. Wai |Theodore Leng

Request Username Can't sign in? Forgot your username?

Jan 5, 2024 | journals.healio.com | Karen M. Wai |Theodore Leng |Brian Chhoy

IntroductionFibroblast growth factor receptors (FGFR) are a family of receptor tyrosine kinases involved in cell proliferation, cell migration, cell differentiation, and cell apoptosis. Overexpression of FGFR can cause abnormal cancer cell proliferation in cancers such as breast, glioblastoma, and hepatocellular cell carcinoma, and is thus the target of many chemotherapy agents. This class of drugs shows promise in targeted anti-cancer therapy.